Influence of vitrectomyon the progressionof wet age related macular degeneration

Cover Page


Cite item

Full Text

Abstract

Purpose. To study the effects of vitrectomy on the course of wet age-related macular degeneration (AMD). Materials and methods. 99 patients (99 eyes) with wet AMD associated with vitreo-macular adhesion or posterior hyaloid traction were included in the study. During the first 6 months, all patients received anti-VEGF treatment according to a PRN regimen. Then, they were divided into two groups: in 45 patients vitrectomy was performed and 54 patients did not receive surgical treatment. The follow-up period duration was one year. Results. At the beginning of the study, visual acuity was 0.27 ± 0.17 in the control group, and 0.17 ± 0.15 in the treatment group. Most prominent differences in visual acuity between the two groups were observed during the first 6 months (visual acuity in the treatment group before surgery was 0.12 ± 0.1) (p < 0.01 and p < 0.001), at the same time during the following 6 follow-up months, this difference decreased (p < 0.05 and p < 0.01). 1 year from the study start, visual acuity in the control group was 0.24 ± 0.17, and 0.17 ± 0.13 in the treatment one. Conclusions. Vitrectomy surgery in patients with wet AMD in association with vitreo-macular adhesion or posterior hyaloid traction does not exacerbate the disease course, stabilizes visual functions and improves the quality of life.

About the authors

Yuriy Sergeyevich Astakhov

First I. P. Pavlov State Medical University of St. Petersburg

Email: astakhov73@mail.ru
MD, doctor of medical science, professor, Department of Ophthalmology

Gassan Basharovich Shaar

First I. P. Pavlov State Medical University of St. Petersburg

Email: ghassan_shaar@mail.ru
postgraduate student, Department of Ophthalmology

Nikita Yur’yevich Dal’

First I. P. Pavlov State Medical University of St. Petersburg

Email: ndahl@yandex.ru
MD, doctor of medical science, professor, head of the department. Department of Ophthalmology

References

  1. Астахов Ю. С., Лисочкина А. Б., Шадричев Ф. Е. Возрастная ма кулярная дегенерация. Клинические рекомендации. Офтальмология/Под ред. Мошетовой Л. К., Нестерова А. П., Егорова Е. А. М.: ГЭОТАР-Медиа. 2006; 164-188.
  2. Bindewald A., Bird A. C., Fitzke F. W. Classification of Fundus Autofluorescence Patterns in Early Age-Related Macular Disease. Invest. Ophthalmol. Vis. Sci. 2005; 46: 3309-3314.
  3. Bird A. C., Bressler N. M., Bressler S. B. An international classifica tion and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv. Ophthalmоl. 1995; 39: 367-374.
  4. Green-Simms A. E., Bakri S. J. Vitreomacular traction and age-rela ted macular degeneration. Semin Ophthalmol. 2011; 26 (3): 137-138.
  5. Hyman L. G., Lilienfeld A. M., Ferris F. L. Senile macular degeneration: a case-control study. Am. J. Epidemiol. 1983; 118: 213-227.
  6. Klein R., Klein B. E., Knudtson M. D. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology2007; 114: 253-262.
  7. Klein R., Klein B. E., Linton K. L. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992; 99: 933-943.
  8. Krebs I., Brannath W., Glittenberg C. Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration? Am. J. Ophthalmol. 2007; 144 (5): 741-746.
  9. Lee S.J., Koh H.J. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration. Ophthalmology. 2011;118(1):101-110.
  10. Ondes F., Yilmaz G., Acar M. A. Role of the vitreous in age-related macular degeneration. JpnJ Ophthalmol. 2000; 44: 91-93.
  11. Schulze S., Hoerle S., Mennel S., Kroll P. Vitreomacular traction and exudative age-related macular degeneration. Acta Ophthalmol. 2008; 86 (5): 470-481.
  12. Spaide R. F., Armstrong D., Brown R. Continuing medical education rewiew: choroidal neovascularization in age-related macular degeneration - what is the cause. Retina. 2003; 23: 595-614.
  13. Stefánsson E., Geirsdóttir A., Sigurdsson H. Metabolic physiology in age related macular degeneration. Prog. Retin. Eye Res. 2011; 30: 72-80.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Astakhov Y.S., Shaar G.B., Dal’ N.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-65574 от 04 мая 2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies